IP Library Assignment 036283/0261
Patent Assignment
Reel/Frame 036283/0261

Change of Name

Recorded: 2015-08-05 Pages: 4
Assignor
APTALIS PHARMATECH, INC.
Executed: 2015-04-29
Assignee
ADARE PHARMACEUTICALS, INC.
1200 LENOX DRIVE, SUITE 100, LAWRENCEVILLE, NEW JERSEY, 08648
Covered Properties (17)
Timed Pulsatile Drug Delivery Systems
Patent: 6,627,223 →
Application: 09/778,645 →
Publication: US 2001/0046964
Timed, Sustained Release Systems for Propranolol
Patent: 6,500,454 →
Application: 09/971,167 →
Extended Release Dosage Forms of Propranolol Hydrochloride
Patent: 8,367,111 →
Application: 10/335,295 →
Publication: US 2004/0126427
Timed, sustained release systems for propranolol
Patent: 9,358,214 →
Application: 10/453,848 →
Publication: US 2004/0047906
Timed Pulsatile Drug Delivery Systems
Patent: 7,048,945 →
Application: 10/675,656 →
Publication: US 2005/0118268
Orally disintegrating tablets of atomoxetine
Patent: 8,747,895 →
Application: 11/223,819 →
Publication: US 2006/0057199
Timed, Sustained Release Systems for Propranolol
Patent: 9,040,086 →
Application: 11/500,892 →
Publication: US 2006/0269607
Drug Delivery Systems Comprising Weakly Basic Selective Serotonin 5-HT3 Blocking Agent and Organic Acids
Application: 11/668,167 →
Publication: US 2007/0190145
Drug Delivery Systems Comprising Weakly Basic Drugs and Organic Acids
Application: 11/668,408 →
Publication: US 2007/0196491
Pharmaceutical Compositions Comprising an Active Substance from the Substituted Benzhydrylpiperazine Family
Patent: 8,962,022 →
Application: 12/057,177 →
Publication: US 2008/0241237
Orally Disintegrating Tablet Compositions of Lamotrigine
Patent: 7,919,115 →
Application: 12/166,757 →
Publication: US 2009/0092672
Drug Delivery Systems Comprising Weakly Basic Drugs and Organic Acids
Patent: 8,133,506 →
Application: 12/209,285 →
Publication: US 2009/0232885
Orally Disintegrating Tablet Compositions of Lamotrigine
Patent: 8,647,656 →
Application: 12/628,677 →
Publication: US 2010/0303905
Rapidly Dispersing Granules, Orally Disintegrating Tablets and Methods
Application: 13/310,632 →
Publication: US 2012/0282335
Orally Disintegrating Tablet Compositions of Lamotrigine
Patent: 8,840,925 →
Application: 13/455,942 →
Publication: US 2013/0108703
Orally Disintegrating Tablet Compositions of Lamotrigine
Patent: 9,339,504 →
Application: 14/172,962 →
Publication: US 2014/0220144
Stablized Modified Release Folic Acid Derivative Composition, Its Therapeutic Use and Methods of Manufacture
Application: 14/445,949 →
Publication: US 2015/0030676
Related Assignments (12)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 4, 2010
From: VENKATESH, GOPI M.; VYAS, NEHAL H.; GOSSELIN, MICHAEL; LAI, JIN-WANG
To: EURAND, INC.
Reel/Frame 023897/0180 →
Change of Name Aug 30, 2012
From: EURAND, INC.
To: APTALIS PHARMATECH, INC.
Reel/Frame 028884/0903 →
Release of Lien on Patents Oct 24, 2013
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: APTALIS PHARMATECH, INC.
Reel/Frame 031494/0925 →
Patent Security Agreement Oct 31, 2013
From: APTALIS PHARMA CANADA INC.; APTALIS PHARMA US, INC.; APTALIS PHARMATECH, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 031531/0488 →
Termination and Release Jan 31, 2014
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: APTALIS PHARMA US, INC.; APTALIS PHARMATECH, INC.; APTALIS PHARMA CANADA INC.
Reel/Frame 032149/0111 →
Change of Name Jul 24, 2014
From: EURAND, INC.
To: APTALIS PHARMATECH, INC.
Reel/Frame 033406/0758 →
Assignment of Assignor's Interest Jul 24, 2014
From: VENKATESH, GOPI M.; VYAS, NEHAL H.; GOSSELIN, MICHAEL; LAI, JIN-WANG
To: EURAND, INC.
Reel/Frame 033383/0570 →
Assignment of Assignor's Interest Aug 15, 2014
From: VENKATESH, GOPI M.; GUILLOT, MICAEL; LAI, JIN-WANG; GOSSELIN, MICHAEL
To: APTALIS PHARMATECH, INC.
Reel/Frame 033545/0726 →
U.S. Patent Security Agreement Dec 8, 2015
From: ADARE PHARMACEUTICALS, INC.
To: BANK OF MONTREAL
Reel/Frame 037246/0313 →
Release of Security Interest Recorded at Reel/Frames 037246/0313, 047807/0967, 053474/0276 Sep 22, 2020
From: BANK OF MONTREAL, AS COLLATERAL AGENT
To: ADARE PHARMACEUTICALS, INC.; ADARE DEVELOPMENT I, L.P.; ADARE PHARMACEUTICALS USA, INC.
Reel/Frame 053852/0697 →
Security Interest Sep 22, 2020
From: ADARE PHARMACEUTICALS, INC.; ADARE PHARMACEUTICALS USA, INC.
To: CRESCENT AGENCY SERVICES LLC, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 053849/0967 →
Security Interest Nov 8, 2022
From: ADARE PHARMACEUTICALS, INC.; ADARE PHARMACEUTICALS USA, INC.
To: TEAL MIDCO HOLDINGS, L.P.
Reel/Frame 061698/0541 →